0
 
About Us <ul><li>Lowell: Wannalancit  </li></ul><ul><li>Focused on Formulation and Analytical Development for Biologics </...
<ul><li>Pre-Formulation/Formulation Development </li></ul><ul><li>Dosage Form Development </li></ul><ul><li>Lyophilization...
About Us <ul><li>ANDOVER </li></ul><ul><li>Construction of CGMP Aseptic Fill/Finish facility began in 2000 in Andover </li...
<ul><li>CGMP Manufacture of Aseptic products for clients in US, Canada, Israel, Australia, NZ, UK, Germany, & Japan. </li>...
Our Experience <ul><li>We have assisted clients with projects in all stages of the regulatory process : </li></ul><ul><li>...
Corporate Objective <ul><li>Customer Service, Satisfaction, and Loyalty </li></ul><ul><li>Quality </li></ul><ul><li>Produc...
Our Mission <ul><li>“ Making a Difference” </li></ul>
Our Logo
Our Motto Doing whatever it takes to build client relationships and ensure repeat business!!!
Our Goal: Meeting Expectations <ul><li>Corporate </li></ul><ul><li>Time-to-Clinic </li></ul><ul><li>Time-to-Market </li></...
Our Successes!! <ul><li>FDA inspected GMP Facility May 2003, July 2005 (No 483’s) </li></ul><ul><li>MHRA inspected & lette...
Our Tag line <ul><li>“ Helping make new drugs happen… at the speed of science” </li></ul>
<ul><li>Management Strength and Vision </li></ul><ul><li>Manufacturing and Development </li></ul><ul><li>Proven Track Reco...
Contract Services Out-License Technology In-License Products The Golden Key Management: Vision
PERFORMANCE
Performance
 
Upcoming SlideShare
Loading in...5
×

Marketing II: Indu Isaacs

836

Published on

Published in: Business, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
836
On Slideshare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "Marketing II: Indu Isaacs"

  1. 2. About Us <ul><li>Lowell: Wannalancit </li></ul><ul><li>Focused on Formulation and Analytical Development for Biologics </li></ul>
  2. 3. <ul><li>Pre-Formulation/Formulation Development </li></ul><ul><li>Dosage Form Development </li></ul><ul><li>Lyophilization Development </li></ul><ul><li>Analytical Development & Validations </li></ul><ul><li>Cell Culture Development </li></ul><ul><li>Purification Development </li></ul>Contract Development Services
  3. 4. About Us <ul><li>ANDOVER </li></ul><ul><li>Construction of CGMP Aseptic Fill/Finish facility began in 2000 in Andover </li></ul><ul><li>CGMP Aseptic Manufacturing suite March 2001 </li></ul><ul><li>35,000 ft 2 Facility & ~ 75 Staff </li></ul>
  4. 5. <ul><li>CGMP Manufacture of Aseptic products for clients in US, Canada, Israel, Australia, NZ, UK, Germany, & Japan. </li></ul><ul><ul><li>Materials for Toxicological testing </li></ul></ul><ul><ul><li>Clinical Trials (Phases I, II and III) </li></ul></ul>Contract Manufacturing Services
  5. 6. Our Experience <ul><li>We have assisted clients with projects in all stages of the regulatory process : </li></ul><ul><li>Discovery </li></ul><ul><li>Pre-clinical </li></ul><ul><li>Clinical </li></ul><ul><li>Post Approval </li></ul>
  6. 7. Corporate Objective <ul><li>Customer Service, Satisfaction, and Loyalty </li></ul><ul><li>Quality </li></ul><ul><li>Productivity/Capabilities/Efficiency </li></ul>
  7. 8. Our Mission <ul><li>“ Making a Difference” </li></ul>
  8. 9. Our Logo
  9. 10. Our Motto Doing whatever it takes to build client relationships and ensure repeat business!!!
  10. 11. Our Goal: Meeting Expectations <ul><li>Corporate </li></ul><ul><li>Time-to-Clinic </li></ul><ul><li>Time-to-Market </li></ul><ul><li>Agency </li></ul><ul><li>Consistent Process </li></ul><ul><li>Stable Dosage Form </li></ul>
  11. 12. Our Successes!! <ul><li>FDA inspected GMP Facility May 2003, July 2005 (No 483’s) </li></ul><ul><li>MHRA inspected & letter of EU GMP compliance (1st in the US) (3 times) </li></ul><ul><li>200+ manufacturing clients globally </li></ul><ul><li>Synagis® and Humira® Development </li></ul><ul><li>High antibody concentration formulations </li></ul><ul><li>Orally Bioavailable Peptide in a capsule </li></ul><ul><li>Solubilization of Insoluble molecules </li></ul><ul><ul><ul><ul><li>IP Spun off as neu MirR x Corp </li></ul></ul></ul></ul>
  12. 13. Our Tag line <ul><li>“ Helping make new drugs happen… at the speed of science” </li></ul>
  13. 14. <ul><li>Management Strength and Vision </li></ul><ul><li>Manufacturing and Development </li></ul><ul><li>Proven Track Record </li></ul><ul><li>Strong Global Marketing & Clientele </li></ul>Our Strategic Advantage
  14. 15. Contract Services Out-License Technology In-License Products The Golden Key Management: Vision
  15. 16. PERFORMANCE
  16. 17. Performance
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×